Financial Information Show all 2021 Q4 Syndax Pharmaceuticals Reports Fourth Quarter 2021 Financial Results and Provides Clinical and Business Update Form 10-K Proxy Statements Filing date View 03.30.22 View HTML 0001564590-22-012595.pdf 0001564590-22-012595.xls Form 10-K Filing date View 03.01.22 View HTML 0001564590-22-008112.pdf 0001564590-22-008112.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q Filing date View 05.09.22 View HTML 0001564590-22-018873.pdf 0001564590-22-018873.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA 11.15.21 View HTML 0001564590-21-057004.pdf 0001564590-21-057004.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
